SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-06-100799
Filing Date
2006-05-05
Accepted
2006-05-04 21:43:55
Documents
4
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT NO.1 d10ka.htm 10-K/A 56714
2 LICENSE DEVELOPMENT AND SUPPLY AGREEMENT dex1054.htm EX-10.54 120788
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 5216
4 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 5231
  Complete submission text file 0001193125-06-100799.txt   189687
Mailing Address 707 EAGLEVIEW BOULEVARD SUITE 414 EXTON PA 19341
Business Address 707 EAGLEVIEW BOULEVARD SUITE 414 EXTON PA 19341 610-458-6200
ANTARES PHARMA INC (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: MN | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-32302 | Film No.: 06810452
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10